Harvey Investment CO LLC Abb Vie Inc. Transaction History

Harvey Investment CO LLC

$836 Million
Q2 2024

A detailed history of Harvey Investment CO LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Harvey Investment CO LLC holds 80,116 shares of ABBV stock, worth $15.5 Million. This represents 1.64% of its overall portfolio holdings.

Number of Shares

80,116

Previous 80,841 0.9%

Holding current value

$15.5 Million

Previous $14.7 Million 6.66%

% of portfolio

1.64%

Previous 1.66%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$154.79 - $180.76 $112,222 - $131,051	-725 Reduced 0.9%	80,116 $13.7 Million
Q1 2024 Apr 24, 2024	SELL	$159.82 - $182.1 $60,891 - $69,380	-381 Reduced 0.47%	80,841 $14.7 Million
Q4 2023 Jan 24, 2024	SELL	$137.6 - $154.97 $738,774 - $832,033	-5,369 Reduced 6.2%	81,222 $12.6 Million
Q3 2023 Oct 18, 2023	SELL	$133.59 - $154.65 $292,562 - $338,683	-2,190 Reduced 2.47%	86,591 $12.9 Million
Q2 2023 Jul 25, 2023	SELL	$132.51 - $164.9 $647,973 - $806,361	-4,890 Reduced 5.22%	88,781 $12 Million
Q1 2023 May 08, 2023	SELL	$144.61 - $166.54 $263,913 - $303,935	-1,825 Reduced 1.91%	93,671 $14.9 Million
Q4 2022 Jan 20, 2023	SELL	$138.31 - $165.87 $48,408 - $58,054	-350 Reduced 0.37%	95,496 $15.4 Million
Q3 2022 Oct 17, 2022	SELL	$134.21 - $153.93 $33,552 - $38,482	-250 Reduced 0.26%	95,846 $12.9 Million
Q2 2022 Jul 19, 2022	SELL	$137.62 - $174.96 $63,029 - $80,131	-458 Reduced 0.47%	96,096 $14.7 Million
Q1 2022 Apr 20, 2022	SELL	$131.98 - $163.75 $150,061 - $186,183	-1,137 Reduced 1.16%	96,554 $15.7 Million
Q4 2020 Jan 21, 2021	SELL	$80.49 - $108.67 $6,439 - $8,693	-80 Reduced 0.08%	97,691 $10.5 Million
Q1 2020 Apr 21, 2020	SELL	$64.5 - $97.79 $167,700 - $254,254	-2,600 Reduced 2.59%	97,771 $7.45 Million
Q3 2019 Oct 21, 2019	SELL	$62.98 - $75.72 $176,344 - $212,016	-2,800 Reduced 2.71%	100,371 $7.6 Million
Q2 2019 Jul 16, 2019	SELL	$65.7 - $83.98 $45,990 - $58,786	-700 Reduced 0.67%	103,171 $7.5 Million
Q1 2019 Apr 11, 2019	SELL	$77.14 - $90.79 $522,777 - $615,283	-6,777 Reduced 6.12%	103,871 $8.37 Million
Q4 2018 Jan 31, 2019	BUY	$77.85 - $96.01 $21,798 - $26,882	280 Added 0.25%	110,648 $10.2 Million
Q3 2018 Oct 22, 2018	SELL	$88.91 - $98.84 $9.88 Million - $11 Million	-111,068 Closed	0 $0
Q2 2018 Jul 24, 2018	SELL	$89.78 - $106.23 $43,363 - $51,309	-483 Reduced 0.43%	111,068 $10.3 Million
Q1 2018 Apr 23, 2018	BUY	$92.01 - $123.21 $56,402 - $75,527	613 Added 0.55%	111,551 $10.6 Million
Q3 2017 Oct 18, 2017	BUY	$69.85 - $89.22 $7.75 Million - $9.9 Million	110,938	110,938 $9.86 Million

Others Institutions Holding ABBV

# of Institutions

3,689

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvey Investment CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvey Investment CO LLC with notifications on news.

Account

Harvey Investment CO LLC Abb Vie Inc. Transaction History